Exane Derivatives’s Insulet PODD Stock Holding History

Exane Derivatives’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-452	Closed	-$118K	–	1076
2021 Q1	$118K	Buy	+452	New	+$121K	0.03%	398

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Exane Derivatives's PODD Position: Q2 2021 in Review

Exane Derivatives sold out of Insulet (PODD) in Q2 2021, closing a stake of 452 shares — an estimated $118K sold.

Exane Derivatives first reported a position in PODD in Q1 2021 and held it in 1 quarter. The position peaked at $118K in Q1 2021. 463 funds tracked by Wall St. Rank hold PODD as of Q2 2021.

Exane Derivatives reported no remaining Insulet position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 452 Insulet shares in Q2 2021, an estimated $118K.
Exane Derivatives first reported a position in Insulet in Q1 2021 and held it in 1 quarter.
Exane Derivatives's Insulet position peaked at $118K in Q1 2021.
463 funds tracked by Wall St. Rank held Insulet as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.